Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review

Refractory dyspnoea can be a challenging symptom to manage. Palliative care specialists are not always available for consultation, and while many clinicians may undergo training in palliative care, this education is not universal. Opioids are the most studied and prescribed pharmacological intervent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Postgraduate medical journal 2023-05, Vol.99 (1169), p.139
Hauptverfasser: Karlic, Kevin J, Hummel, Ellen K, Houchens, Nathan, Meddings, Jennifer
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1169
container_start_page 139
container_title Postgraduate medical journal
container_volume 99
creator Karlic, Kevin J
Hummel, Ellen K
Houchens, Nathan
Meddings, Jennifer
description Refractory dyspnoea can be a challenging symptom to manage. Palliative care specialists are not always available for consultation, and while many clinicians may undergo training in palliative care, this education is not universal. Opioids are the most studied and prescribed pharmacological intervention for refractory dyspnoea; however, many clinicians hesitate to prescribe opioids due to regulatory concerns and fear of adverse effects. Current evidence suggests that rates of severe adverse effects, including respiratory depression and hypotension, are low when opioids are administered for refractory dyspnoea. Therefore, systemic, short-acting opioids are a recommended and safe option for the palliation of refractory dyspnoea in patients with serious illness, especially in a hospital setting that facilitates close observation. In this narrative review, we discuss the pathophysiology of dyspnoea; facilitate an evidence-based discussion on the concerns, considerations and complications associated with opioid administration for refractory dyspnoea; and describe one approach to managing refractory dyspnoea.
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_37222051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37222051</sourcerecordid><originalsourceid>FETCH-pubmed_primary_372220513</originalsourceid><addsrcrecordid>eNqFjksKwjAQQIMg_q8gcwEhaatFt6J4AF1LNFM6UpMwEy29vV3o2tXbPB5voCam2GxXulxvxmoq8tDa5GVhRmqcl1mW6bWZqPoiCKGCECmQE6gCA2PF9p4Cd-A6iT6gBfJQB4mUbEOCDqJNhD4JtJRqEGQKLwFqGo8iO7DgLXPvvLHPvQnbuRpWthFcfDlTy-PhvD-t4uv2RHeNTE_L3fW3lv8VPuuMRiU</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review</title><source>MEDLINE</source><source>Oxford University Press Journals Current</source><creator>Karlic, Kevin J ; Hummel, Ellen K ; Houchens, Nathan ; Meddings, Jennifer</creator><creatorcontrib>Karlic, Kevin J ; Hummel, Ellen K ; Houchens, Nathan ; Meddings, Jennifer</creatorcontrib><description>Refractory dyspnoea can be a challenging symptom to manage. Palliative care specialists are not always available for consultation, and while many clinicians may undergo training in palliative care, this education is not universal. Opioids are the most studied and prescribed pharmacological intervention for refractory dyspnoea; however, many clinicians hesitate to prescribe opioids due to regulatory concerns and fear of adverse effects. Current evidence suggests that rates of severe adverse effects, including respiratory depression and hypotension, are low when opioids are administered for refractory dyspnoea. Therefore, systemic, short-acting opioids are a recommended and safe option for the palliation of refractory dyspnoea in patients with serious illness, especially in a hospital setting that facilitates close observation. In this narrative review, we discuss the pathophysiology of dyspnoea; facilitate an evidence-based discussion on the concerns, considerations and complications associated with opioid administration for refractory dyspnoea; and describe one approach to managing refractory dyspnoea.</description><identifier>EISSN: 1469-0756</identifier><identifier>PMID: 37222051</identifier><language>eng</language><publisher>England</publisher><subject>Analgesics, Opioid ; Drug-Related Side Effects and Adverse Reactions ; Dyspnea ; Educational Status ; Humans ; Respiratory Insufficiency</subject><ispartof>Postgraduate medical journal, 2023-05, Vol.99 (1169), p.139</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of Postgraduate Medical Journal. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-8699-1498</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37222051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karlic, Kevin J</creatorcontrib><creatorcontrib>Hummel, Ellen K</creatorcontrib><creatorcontrib>Houchens, Nathan</creatorcontrib><creatorcontrib>Meddings, Jennifer</creatorcontrib><title>Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review</title><title>Postgraduate medical journal</title><addtitle>Postgrad Med J</addtitle><description>Refractory dyspnoea can be a challenging symptom to manage. Palliative care specialists are not always available for consultation, and while many clinicians may undergo training in palliative care, this education is not universal. Opioids are the most studied and prescribed pharmacological intervention for refractory dyspnoea; however, many clinicians hesitate to prescribe opioids due to regulatory concerns and fear of adverse effects. Current evidence suggests that rates of severe adverse effects, including respiratory depression and hypotension, are low when opioids are administered for refractory dyspnoea. Therefore, systemic, short-acting opioids are a recommended and safe option for the palliation of refractory dyspnoea in patients with serious illness, especially in a hospital setting that facilitates close observation. In this narrative review, we discuss the pathophysiology of dyspnoea; facilitate an evidence-based discussion on the concerns, considerations and complications associated with opioid administration for refractory dyspnoea; and describe one approach to managing refractory dyspnoea.</description><subject>Analgesics, Opioid</subject><subject>Drug-Related Side Effects and Adverse Reactions</subject><subject>Dyspnea</subject><subject>Educational Status</subject><subject>Humans</subject><subject>Respiratory Insufficiency</subject><issn>1469-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFjksKwjAQQIMg_q8gcwEhaatFt6J4AF1LNFM6UpMwEy29vV3o2tXbPB5voCam2GxXulxvxmoq8tDa5GVhRmqcl1mW6bWZqPoiCKGCECmQE6gCA2PF9p4Cd-A6iT6gBfJQB4mUbEOCDqJNhD4JtJRqEGQKLwFqGo8iO7DgLXPvvLHPvQnbuRpWthFcfDlTy-PhvD-t4uv2RHeNTE_L3fW3lv8VPuuMRiU</recordid><startdate>20230519</startdate><enddate>20230519</enddate><creator>Karlic, Kevin J</creator><creator>Hummel, Ellen K</creator><creator>Houchens, Nathan</creator><creator>Meddings, Jennifer</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0001-8699-1498</orcidid></search><sort><creationdate>20230519</creationdate><title>Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review</title><author>Karlic, Kevin J ; Hummel, Ellen K ; Houchens, Nathan ; Meddings, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_372220513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analgesics, Opioid</topic><topic>Drug-Related Side Effects and Adverse Reactions</topic><topic>Dyspnea</topic><topic>Educational Status</topic><topic>Humans</topic><topic>Respiratory Insufficiency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karlic, Kevin J</creatorcontrib><creatorcontrib>Hummel, Ellen K</creatorcontrib><creatorcontrib>Houchens, Nathan</creatorcontrib><creatorcontrib>Meddings, Jennifer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Postgraduate medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karlic, Kevin J</au><au>Hummel, Ellen K</au><au>Houchens, Nathan</au><au>Meddings, Jennifer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review</atitle><jtitle>Postgraduate medical journal</jtitle><addtitle>Postgrad Med J</addtitle><date>2023-05-19</date><risdate>2023</risdate><volume>99</volume><issue>1169</issue><spage>139</spage><pages>139-</pages><eissn>1469-0756</eissn><abstract>Refractory dyspnoea can be a challenging symptom to manage. Palliative care specialists are not always available for consultation, and while many clinicians may undergo training in palliative care, this education is not universal. Opioids are the most studied and prescribed pharmacological intervention for refractory dyspnoea; however, many clinicians hesitate to prescribe opioids due to regulatory concerns and fear of adverse effects. Current evidence suggests that rates of severe adverse effects, including respiratory depression and hypotension, are low when opioids are administered for refractory dyspnoea. Therefore, systemic, short-acting opioids are a recommended and safe option for the palliation of refractory dyspnoea in patients with serious illness, especially in a hospital setting that facilitates close observation. In this narrative review, we discuss the pathophysiology of dyspnoea; facilitate an evidence-based discussion on the concerns, considerations and complications associated with opioid administration for refractory dyspnoea; and describe one approach to managing refractory dyspnoea.</abstract><cop>England</cop><pmid>37222051</pmid><orcidid>https://orcid.org/0000-0001-8699-1498</orcidid></addata></record>
fulltext fulltext
identifier EISSN: 1469-0756
ispartof Postgraduate medical journal, 2023-05, Vol.99 (1169), p.139
issn 1469-0756
language eng
recordid cdi_pubmed_primary_37222051
source MEDLINE; Oxford University Press Journals Current
subjects Analgesics, Opioid
Drug-Related Side Effects and Adverse Reactions
Dyspnea
Educational Status
Humans
Respiratory Insufficiency
title Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20opioids%20for%20refractory%20dyspnoea%20in%20hospitalised%20patients%20with%20serious%20illness:%20a%20narrative%20review&rft.jtitle=Postgraduate%20medical%20journal&rft.au=Karlic,%20Kevin%20J&rft.date=2023-05-19&rft.volume=99&rft.issue=1169&rft.spage=139&rft.pages=139-&rft.eissn=1469-0756&rft_id=info:doi/&rft_dat=%3Cpubmed%3E37222051%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37222051&rfr_iscdi=true